Long noncoding RNA TFAP2A-AS1 promotes oral squamous cell carcinoma cell growth and movement via competitively binding miR-1297 and regulating TFAP2A expression
- PMID: 35730908
- DOI: 10.1002/mc.23438
Long noncoding RNA TFAP2A-AS1 promotes oral squamous cell carcinoma cell growth and movement via competitively binding miR-1297 and regulating TFAP2A expression
Abstract
Oral squamous cell carcinoma (OSCC) is an aggressive and common malignancy in the head and neck, characterized by poor prognosis and high incidence. This study aimed to investigate the role of long noncoding RNA TFAP2A-AS1 in OSCC. The competing endogenous RNA network of TFAP2A-AS1 was constructed by bioinformatics analysis. The expressions of miR-1297, TFAP2A-AS1, and TFAP2A were measured by quantitative reverse transcription-polymerase chain reaction. The correlations of TFAP2A-AS1, miR-1297, and TFAP2A with clinicopathological characteristics of OSCC were assessed. RNA immunoprecipitation and dual-luciferase reporter assay were used to identify the target of miR-1297. Cell proliferation was measured by colony formation assay and [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] assay. Transwell assay and wound healing assay were performed to assess cell movement. TFAP2A-AS1 and TFAP2A were upregulated in OSCC and their expression levels were positively correlated. The levels of TFAP2A-AS1, miR-1297, and TFAP2A were also associated with lymphatic metastasis and the tumor-node-metastasis (TNM) stage of OSCC patients. TFAP2A-AS1 acted as a miR-1297 sponge. OSCC cell growth and movement were inhibited by miR-1297. Changes in the miR-1297 expression abolished the effects of TFAP2A-AS1 on OSCC cells. Additionally, TFAP2A was a target of miR-1297. TFAP2A promoted OSCC cell growth and migration/invasion, indicating that TFAP2A mediated the effects of TFAP2A-AS1 and miR-1297. TFAP2A-AS1 exerts an oncogenic effect in OSCC via the TFAP2A-AS1/miR-1297/TFAP2A axis, which may provide new targets and strategies for OSCC treatments.
Keywords: TFAP2A; TFAP2A-AS1; miR-1297; oral squamous cell carcinoma.
© 2022 Wiley Periodicals LLC.
Similar articles
-
RELA promotes the progression of oral squamous cell carcinoma via TFAP2A-Wnt/β-catenin signaling.Mol Carcinog. 2023 May;62(5):641-651. doi: 10.1002/mc.23512. Epub 2023 Feb 15. Mol Carcinog. 2023. PMID: 36789977
-
FOXD2-AS1 promotes malignant cell behavior in oral squamous cell carcinoma via the miR-378 g/CRABP2 axis.BMC Oral Health. 2024 May 28;24(1):625. doi: 10.1186/s12903-024-04388-2. BMC Oral Health. 2024. PMID: 38807101 Free PMC article.
-
Long non-coding RNA TFAP2A-AS1 plays an important role in oral squamous cell carcinoma: research includes bioinformatics analysis and experiments.BMC Oral Health. 2022 May 6;22(1):160. doi: 10.1186/s12903-022-02203-4. BMC Oral Health. 2022. PMID: 35524329 Free PMC article.
-
A snapshot of miRNAs in oral squamous cell carcinoma: Difference between cancer cells and corresponding normal cells.Pathol Res Pract. 2023 Sep;249:154731. doi: 10.1016/j.prp.2023.154731. Epub 2023 Jul 29. Pathol Res Pract. 2023. PMID: 37573620 Review.
-
Review of Disease-Specific microRNAs by Strategically Bridging Genetics and Epigenetics in Oral Squamous Cell Carcinoma.Genes (Basel). 2023 Aug 2;14(8):1578. doi: 10.3390/genes14081578. Genes (Basel). 2023. PMID: 37628629 Free PMC article. Review.
Cited by
-
AP-2α gene deregulation is associated with renal cell carcinoma patient survival.BMC Cancer. 2024 Aug 7;24(1):966. doi: 10.1186/s12885-024-12526-w. BMC Cancer. 2024. PMID: 39112969 Free PMC article.
-
Crucial role of the transcription factors family activator protein 2 in cancer: current clue and views.J Transl Med. 2023 Jun 8;21(1):371. doi: 10.1186/s12967-023-04189-1. J Transl Med. 2023. PMID: 37291585 Free PMC article. Review.
-
Potential prognosis and immunotherapy predictor TFAP2A in pan-cancer.Aging (Albany NY). 2024 Jan 23;16(2):1021-1048. doi: 10.18632/aging.205225. Epub 2024 Jan 23. Aging (Albany NY). 2024. PMID: 38265973 Free PMC article.
-
TFAP2A promotes cervical cancer via a positive feedback pathway with PD‑L1.Oncol Rep. 2023 Jun;49(6):114. doi: 10.3892/or.2023.8551. Epub 2023 Apr 21. Oncol Rep. 2023. PMID: 37083077 Free PMC article.
References
REFERENCES
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424.
-
- Ong TK, Murphy C, Smith AB, Kanatas AN, Mitchell DA. Survival after surgery for oral cancer: a 30-year experience. Br J Oral Maxillofac Surg. 2017;55(9):911-916.
-
- Ding D, Stokes W, Eguchi M, et al. Association between lymph node ratio and recurrence and survival outcomes in patients with oral cavity cancer. JAMA Otolaryngol Head Neck Surg. 2019;145(1):53-61.
-
- Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018;172(3):393-407.
-
- Beermann J, Piccoli MT, Viereck J, Thum T. Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol Rev. 2016;96(4):1297-1325.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical